October 28-29, 2024 | Boston, MA

Identifying and Advancing Novel Pain Drugs Through Preclinical, Clinical Development and Commercialization

Press Releases

June 21, 2016

Vivozon to Present Practical Methodology in Identifying Antionociceptive Multi-Target Drugs at Upcoming 10th Annual Pain Therapeutics Summit

As the steady decline of newly developed single-targeted drugs is becoming a challenge in the field, researchers are preferring to use a practical methodology in identifying antionociceptive multi-target drugs. The design of this approach allows for drugs to reflect multifactorial diseases caused by intricate networks of various mechanisms.

August 13, 2012

Advances in Chronic Migraine Treatment

Chronic migraine (CM) and episodic migraine (EM) are part of the spectrum of migraine disorders, but they are distinct clinical entities. Episodic migraine (EM) is characterized by those with migraine who have 0 to 14 headache days per month, while chronic migraine (CM) is characterized by 15 or more headache days per month.
 

About Us

Our conferences offer more than simply presentations; we offer an experience that encompasses learning, networking and professional growth. We focus on bringing life sciences industry professionals together to help move research forward. 
READ MORE